Brief: Coherus, Zumutor To Collaborate On ZM008, LOQTORZI Combination Study
23/06/2026 19:05
BRIEF-Coherus, Zumutor To Collaborate On ZM008, LOQTORZI Combination Study June 23 (Reuters) - Coherus Oncology Inc CHRS.O:
COHERUS AND ZUMUTOR BIOLOGICS ANNOUNCE CLINICAL COLLABORATION TO EVALUATE ZM008 IN COMBINATION WITH LOQTORZI® (TORIPALIMAB-TPZI)
COHERUS ONCOLOGY: CO TO SUPPLY LOQTORZI; ZUMUTOR TO SPONSOR PHASE 1 TRIAL; BOTH RETAIN COMMERCIAL RIGHTS
Source text: ID:nGNX2qfx71
Further company coverage: CHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million